[go: up one dir, main page]

CA2401295A1 - Procede de production de produits antiviraux issus d'extraits de plantes - Google Patents

Procede de production de produits antiviraux issus d'extraits de plantes Download PDF

Info

Publication number
CA2401295A1
CA2401295A1 CA002401295A CA2401295A CA2401295A1 CA 2401295 A1 CA2401295 A1 CA 2401295A1 CA 002401295 A CA002401295 A CA 002401295A CA 2401295 A CA2401295 A CA 2401295A CA 2401295 A1 CA2401295 A1 CA 2401295A1
Authority
CA
Canada
Prior art keywords
virus
compositions
hepatitis
hiv
chinese herbal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002401295A
Other languages
English (en)
Other versions
CA2401295C (fr
Inventor
Shie-Ming Hwang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAGE R&D Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from CA002271622A external-priority patent/CA2271622C/fr
Publication of CA2401295A1 publication Critical patent/CA2401295A1/fr
Application granted granted Critical
Publication of CA2401295C publication Critical patent/CA2401295C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
CA002401295A 1996-07-09 1997-07-09 Procede de production de produits antiviraux issus d'extraits de plantes Expired - Fee Related CA2401295C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1610096P 1996-07-09 1996-07-09
US60/016100 1996-07-09
US2146796P 1996-07-10 1996-07-10
US60/021467 1996-07-10
CA002271622A CA2271622C (fr) 1996-07-09 1997-07-09 Agents antiviraux issus d'extraits de plantes et utilisation de ces agents dans le traitement d'infections virales

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002271622A Division CA2271622C (fr) 1996-07-09 1997-07-09 Agents antiviraux issus d'extraits de plantes et utilisation de ces agents dans le traitement d'infections virales

Publications (2)

Publication Number Publication Date
CA2401295A1 true CA2401295A1 (fr) 1998-01-15
CA2401295C CA2401295C (fr) 2008-01-29

Family

ID=27170967

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002401295A Expired - Fee Related CA2401295C (fr) 1996-07-09 1997-07-09 Procede de production de produits antiviraux issus d'extraits de plantes

Country Status (1)

Country Link
CA (1) CA2401295C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115487106A (zh) * 2022-08-09 2022-12-20 北京康华远景科技股份有限公司 一种黄芩提取物的循环酸沉制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115487106A (zh) * 2022-08-09 2022-12-20 北京康华远景科技股份有限公司 一种黄芩提取物的循环酸沉制备方法

Also Published As

Publication number Publication date
CA2401295C (fr) 2008-01-29

Similar Documents

Publication Publication Date Title
CA2271622A1 (fr) Agents antiviraux issus d'extraits de plantes et utilisation de ces agents dans le traitement d'infections virales
WO1998001144A2 (fr) Agents antiviraux issus d"extraits de plantes et utilisation de ces agents dans le traitement d"infections virales
WO2003063771A3 (fr) Nucleosides n4-acylcytosines pour le traitement d'infections virales
WO2001010456A3 (fr) Peptides bloquant les infections virales et procedes d'utilisation correspondants
CA2165821A1 (fr) Oligonucleotides antisens et utilisation therapeutique de ceux-ci dans l'infection par le virus de l'immunodeficience humaine
CA2198010A1 (fr) Succinate de 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2- cyclopentene-1-methanol, agent antiviral
EP0355825A3 (fr) Système du traitement viral
AU1226288A (en) Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome
EP0681578A1 (fr) Composes de naphtoquinone antiviraux, compositions les contenant et utilisations de ces composes.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
AU3530293A (en) Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV)
CA2401295A1 (fr) Procede de production de produits antiviraux issus d'extraits de plantes
DK720588D0 (da) Forbindelser til anvendelse ved behandling eller forebyggelse af human-immundefektvirus-(hiv)-infektion, og farmaceutiske praeparater indeholdende samme
MY157594A (en) Compositions of matter useful in the treatment of viral infections derived from plant extracts
AP9600896A0 (en) Anti-HIV triple combination.
EP0316592A3 (fr) 3'-Fluoro-2',3'-didéoxyuridine, et ses application thérapeutique
EP0963441A4 (fr) Therapie de l'infection a virus de l'immunodeficience humaine (vih) par inactivation de co-recepteurs du vih
UA42693C2 (uk) Лікарський засіб для лікування інфекції лентивірусом, препарат для лікування людини, яка інфікована лентивірусом
EP0362755A3 (fr) Clone de cellules-t cytotoxiques humaines et anticorps contre ce clone
Cottone et al. Hepatitis, HIV infection and AIDS: some issues for the practitioner
AU3593095A (en) Method of treatment of human immunodeficiency virus (hiv) infection
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
GR960300005T1 (en) Extracts of piliostigma thonningii, the use thereof and formulations containing them.
CA2088788A1 (fr) Peptides entravant les infections par le virus de l'immunodeficience humaine et methodes d'utilisation correspondantes
WO2001030325A3 (fr) Utilisation d'un inhibiteur de la phosphotyrosylphosphatase dans le traitement de patients immunodeprimes

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed